In order 10 determine the sensitivity of Ihe procedurefor detteling and measuring pharmacological intervention in Ihe pulmonary endothelial amine receptors, propranolol WclS administered intravenously to the intact dogs 01 different dose levels. Pulmonary ex/rac/ion of 
INTRODUCfION
In addition to its major role as the organ o f external gas exchange the pulmonary ci rcu lation in the lung also serves as a metabolic regulator of substances ci rculating in the blood. Evidence suggests that t he lungs can remove and deactivate circulating vasoact ive am ines; many substances that act on the vascular or central nervous system, including norepi nephrine, serotonin , prostaglandin. and bradykinin, are selectively removed by the endothelial cells of the lungs. (I) Analyses o f the metabolic fu nct ions of the lung, especially the lung's effect o n the concen tration on circulating bioamines such as amphetamine and other amines have opened a new vista of lung research into the study of the metabolic fun ctions. mechanism of extraction and physiological perturbation.
The potential for using gamma emission imaging technique to visualize metabolic processes of the lung has been studied by other investigators. Fowler et al (2) have demonstrated the potential of C-II Octylamine in vivo as a diagnostic agent for the lung st ructure and function in rabbits. Gallagher et al (3) using C-II Octylamine in humans, showed an initial high uptake in the lungs. Syrota et al (4) have reported uptake of C·I I ch lorpromazine in human lungs. Rahimian report, attempts are made to clari fy the mechanism of IM P uptak.e with other amine pharmaceutical (propranolol) that has been studied in considerable detail by other investigators. Competitive interaction between IMP and propranolol ind icates that the in vivo procedure has enough sensi tivity to measure drugs and metabolic interactions in the lung receptors. The feasibi lity of such procedure will enable to study pulmonary physiology in health and disease.
MATERIALS AND M ETHODS
Four dogs were used in both control and experimental studies. The dogs weighing 17 to 20 kg were anesthet ized with an int ravenous dose of the short acting barbiturate, thiamylal. approximately 15 minutes prior to inj ection of the reference tracer. These dogs were free of known diseases and were provided a week of rest, before being used in any of the present studies. No medication was administered to the dogs during thi s time.
The dual indicator dilution technique was used to study the effect of the pulmonary extraction of IMP with and without the influence of pharmacological intervention of propranolol. A 3 to 4 mCi of Tc-99m dextran (reference tracer) was followed by a bolus of 3 to 4 mCi of 1-123 IMP (test tracer). The competing substance propranolol was injected 10 minutes prior to the reference tracer. The same inj ection si te and technique were used for each bolus. 20'70 windows were used at 140 KeY for Tc-99m and at 159 KeY for 1-123. The distribution of radioactivity in different o rgans invivo was cOnlinuously monitored with a large field of view (LFOV) scintillation camera. The camera was interfaced with a PDP 11 / 40 computer. In fo rmation generated was recorded in 64 x 64 matrices. The frame mode resolution time was 4 fram es per second for 25 seconds.
DATA ANALVSIS Dual indicator dilution technique was used in this study. The reference vascular system , the test tracer (IMP) whose extraction was to be determined . Sep. arate injections of tracers under stable ph ysiological conditions were employed in this study.
Righi heart and lung time·activity curves generated for each individual adminislered tracer and were cor· reeled for background . Time·activity curves of the right heart and lung for the reference and test tracers were fiued with a gamma variate of the form R(t) "" Kte(e · lI~ (I) Where t = time after injeclion R(t) IE radiotracer concent ration at time, t K ". constant scale faclor .... ,~ = are Ihe arbitrary paramelers deter· mining the shape of the curve Gamma variate fits of Ihe right hean and pulmo· nary curves were deconvolved to yield the pulmonary response funct ion of Ihe reference vascular Iracer. The gamma variate fit to the right hean curve for Ihe test tracer is then convolved with the pulmonary im· pulse response funclion of the reference tracer to yield a predicted pulmonary vascu lar curve for the test tracer. The observed and predicted curves for the test tracer were normalized by their respective peak values and are plotted as the residue functions of the actual and predicted test !Tacer (Fig. I) . The extraction was calculated using the equation
Where RT (I) and RR (I) are the normalized residue fu nctions following an impulse injection for the lest and reference tracer . When the injection is very shorl, R(t) can be considered to be eq ual to C(I)/ C(O), where C(t) is the count rate of isotope emissions detected at time 't' and C(O) is the peak observed im· mediately after injection . Therefore, the residue fu nc· tion R(t) assumes fractional values between 0 and 1.0 of the administered dose.
RESULTS
In this study, Ihe pulmonary extraction fraction of IMP was determined four times in four dogs. Fig. I shows the residue fun ction R(t) of the predicted IMP and the observed IMP from which the extraction was taken at the time when the lung curve of the reference tracer had descended to 30a,lo of its peak value. (Fig. 2) The extraction fraction for IMP is 0.90 ± 0.03 when no compeling substance was injected. This result is in confirmil Y with our previous result (4).
R(t)
., After pharmacological intervention with propranolol, however, different extractions were determined. In 15 experiment s, 1,3,.'5,10, 15, and 20 mg o f pro· pranolol were given intravenously 10 minutes prior to the adminstration of reference tracer . The first pass pulmonary extraction ratio of IMP were 0.81,0.77, 0 .71,0.62,0.62, and 0.62 respectively (Fig. 3 ) . 
DISCUSSION
Metabolic lung fun ctions are interrelated having al least a common anatomical place in the pulmonary endothelium. The uptake of active metabolites is done by specific receplOrs in the endothelial membranes. The assessment of these receptors in normal and pathological conditions is an important slep to progress in our knowledge of the lung metabolic func-
lions.
Primary biogenic amine clearance is a carriermediated drug sensitive process linked with uptake into endothelial cells and subsequent breakdown by monoamine oxidase and other enzymes (6) . Lung endothelial receptors, on the other hand. have an active role in the modulation of the neurotransmitter and vasoactive amines_ D-amphetamine specifically binds to pulmonary endothelial amine receptors and IMP behaves very similar to D·amphetamine (7). The high turn over of IMP in the lung indicates that the pro· cedure has enough sensi tivity to measure receptor· mediated metabolic function s of the lung. The first pass pulmonary extraction of IMP in the control dogs was 9O ±30J0. This result is in confirmily with Syrota et al (4) and Gillis et al (8) using C·II chlorpromazine (CPZ) and 5HT in human lungs reported 90'/0 extrac· tion. Rahimian et al (5) also reported 92% extraction of IMP in normal dogs. In order to further evaluate the method for detecting and measuring pharmacological intervention in the pulmonary endothelial amine receptors; propranolol was chosen as an in· vestigative drug for the pharmacological interven tion with IMP.
Experimental and clinical applications of IMP to the study of pulmonary endothelial pathophysiology requires quantitative techniques for measuring its uptake in the lungs, and also demonstrating the competitive effect of beta adrenoceptor antagonists for the binding sites of IMP in the pulmonary blocker.
Propranolol inhibits both ~' and JP, leaving alpha untouched. Mammalian lungs have enormous ability to concentrate propranolol and Pang et al (9) pointed out that up to 94070 of propranolol being removed from the pu lmonary circulation in a single passage. However. the precise ways and means of propranolol uptake in the lung is not been known yet wi th absolute certainty (10) .
Metabolic studies of propranolol indicates thaI at leasl90O'/o of the activity is taken up into the lung slices during a 30 minutes incubation with a labeled propranolol and is accounted for the parent compound itself (II). It has been also concluded that little or no metabolism of propranolol ocurred during this period. Similar findings was reported by Dollery et al (12) in the perfused rat lung using perfusion times of up to 10 minutes. Geddes et a1 (13) reported that 75% of injected propranolol was taken up by the lungs of contious patient s.
Under the innuence of general anesthesia. propran· 0101 uptake after a single passage through the canine pulmonary circulation in vivo was greater than in con· cious dogs (14) . The decrease in cardiac output in the anesthetized dogs may be linked with an enhanced transit time through the lungs, which in turn exposed the pulmonary endothelium for a longer period by the injected propranolol, since the uptake of the drug is thought to occur in endothelial cells (15) . The longer time of exposure, shou ld result in higher turnover of propranolol in the lung. However, change in cardiac output may not be the only explanation since no cor· relation was found between propranolol uptake and the cardiac output in concious dogs (16). although, the range of the cardiac output was less in an anesthetized dogs. The high turnover of propranolol in the lungs may be due to its high lipid solubility. Thi s contention is supported by a positive correlation between the degree of lung uptake and the log partition coeHecient of fl·adrenoceptor antagonist between octonol and buffer (17) . Most likely explanation of propranolol uptake in an anesthetized dog is that anesthetic agents interacts with the endothelial cell membrane and facilitates the uptake o f the lung.
The first pass pulmonary uptake of IMP may be a useful index of probing endothelial cell function. However, it can be disputed that the IMP taken up by the lung will not be taken up mainly by the endothelial cell funClion. However, it can be the most logical assumption to assume that the pulmonary endothelium is the major site of uptake under the time scale of the first pass is very brief and pulmonary endothelial cells are the first one to encounter by administered IMP.
The extraction of the IMP were inhibited as the dose of propranolol increases as shown in Fig. 3 Competitive inhibition is the most likely mechanism of inhibited IMP uptake in the lungs. This is due to the fact that propranolol share the same route as that of IMP. Geddes et a1 (13) have reported that human paliemsaiready on propranolol medication showed less lung uptake of the intravenous dose of propranolol.
The first pass IMP pulmonary extraction ratio was 62'1. under influence of 10 mg of propranolol, whereas 15 and 20 mg of propranolol dose given 10 minutes prior to the reference tracer revealed the same extraction ratio. In this case, attempts have not been made to go beyond 20 mg of propranolol because of the risk of severe depression of cardiovascular function.
The 62'1, first pass pulmonary extraction of IMP in the presence of propranolol obtained in this stud y can be compared with the first pass pulmonary extraction of IMP in the presence of ketamine. The first pass pumonary extraction of IMP in the presence of ketamine was 64'10 (5). This is due to active competition for similar binding sites. Furthermore, in the chronic obstructive lung disease, pulmonary extraction was 64070 usi ng C·II CPZ (4). The results suggest that the pulmonary uptake of IMP may be at least partially mediated by receptors. Furthermore. stud ies of the degree of lung uptake may be a useful index of path· ologic states in which alteralion of amine receptors have occurred. In addition to this. uptake of IMP may provide a sensit ive probe with which to detect and evaluate the physiology o f competitive pharmaco· logical intervention of pulmonary endothelial cell in a clinical environment using a non·invasive procedure.
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